Screener

R&D

Name: Bicara Therapeutics R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Bicara Therapeutics·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$34.33M	$24.8M	$32.98M	$32.99M	$47.5M
Total	$34.3M	$24.8M	$33M	—	—

Business SegmentsView metric